Development and validation of a reversed-phase HPLC method for separation and simultaneous determination of process-related substances of mirtazapine in bulk drugs and formulations

Journal of Chromatographic Science

Volumn 47, Issue 3, 2009, Pages 223-230

  Rao, R Nageswara ^a   Raju, A Narasa ^a  

^a INDIAN INSTITUTE OF CHEMICAL TECHNOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ACETONITRILE; ACETONITRILE DERIVATIVE; BUFFER; DRUG; DRUG DERIVATIVE; ETHYLAMINE; MIANSERIN; MIRTAZAPINE; TRICYCLIC ANTIDEPRESSANT AGENT; TRIETHYLAMINE;

ARTICLE; CHEMISTRY; DRUG CONTAMINATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOLATION AND PURIFICATION; METHODOLOGY; PH; SENSITIVITY AND SPECIFICITY; TEMPERATURE; VALIDATION STUDY;

ACETONITRILES; ANTIDEPRESSIVE AGENTS, TRICYCLIC; BUFFERS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG CONTAMINATION; ETHYLAMINES; HYDROGEN-ION CONCENTRATION; MIANSERIN; PHARMACEUTICAL PREPARATIONS; SENSITIVITY AND SPECIFICITY; TEMPERATURE;

EID: 65449183103     PISSN: 00219665     EISSN: None     Source Type: Journal    
DOI: 10.1093/chromsci/47.3.223     Document Type: Article

References (21)

1. B.E Leonard. Mirtazapine - Noradrenergic and specific seroton-ergic antidepressant (NaSSA). Hum. Psychopharm. 10(Suppl. 2): S81 (1995).
2. R. Davis and M.l. Wilde. Mirtazapine: A review of its pharmacology and therapy potential in the management of major depression. CNS Drugs 5: 389-402 (1996).
3. C.J. Timmer, A.A.M. Lohmann, and C.P.A. Mink. Pharmacokinetic dose-proportionality study at steady state of mirtazapine from Remeron® tablets. Hum. Psychophann. 10: S97-S106 (1995).
4. L.P.C. Delpressine, M.E.G. Moonen, F.M. Kaspersen, G.N. Wagenaars, P.L. Jacobs, C.J. Timmer, J.E. Paanakker, H.J.M. van Hal, and G. Voortman. Pharmacokinetics and biotransformation of mirtazapine in human volunteers. Clin. Drug Invest. 15:45-55(1998).
5. L. Labat, M. Deveaux, P. Dallet, and J.P. Dubost. Separation of new antidepressants and their metabolites by micellar electrokinetic capillary chromatography. J. Chromatogr. B 773:17-23 (2002).
6. C. Sanchez De La Torre, M.A. Martinez, and E. Almarza. Determination of several psychiatric drugs in whole blood using capillary gas-liquid chromatography with nitrogen phosphorus detection: Comparison of two solid phase extraction procedures. Forensic Sci. Int. 155(2-3): 193-204 (2005)
7. C.J. Timmer, J.E. Paanakker, and M. Vrijmoed-de Vries. Mirtazapine pharmacokinetics with two dosage regimens and two pharmaceutical formulations. Pharm. Res. 14(1): 98-102 (1997).
8. C. Frahnert, M.L. Rao, and K. Grasmader. Analysis of eighteen antidepressants, four atypical antipsychotics and active metabolites in serum by liquid chromatography: A simple tool for therapeutic drug monitoring, J. Chromatogr. B 794: 35-47 (2003).
9. T. Romiguieres, F. Pehourcq, M. Matoga, B. Begaud, and C. Jarry. Determination of mirtazapine and its demethyl metabolite in plasma by high-performance liquid chromatography with ultraviolet detection: Application to management of acute intoxication. J. Chromatogr. B 775:163-168 (2002).
10. K. Titier, N. Castaing, E. Scotto-Gommez, F. Perhourcq, N. Moore, and M. Molimard. High-performance liquid Chromatographie method with diode array detection for identification and quantification of the eight new antidepressants and five of their active metabolites in plasma after overdose. Ther. Drug Monit. 25:581-587(2003).
11. C. Duverneuil, Gl. de la Grandmaison, P. de Mazancourt, and J.C. Alvarez. A high-performance liquid chromatography method with photodiode-array UV detection for therapeutic drug monitoring of the nontricyclic antidepressant drugs. Ther. Drug Monit. 25: 565-573 (2003).
12. C. Pistos, M. Koutsopoulou, and I. Panderi. A validated liquid Chromatographie tandem mass spectrometric method for the determination of mirtazapine and demethylmirtazapine in human plasma: Application to a pharmacokinetic study. Anal. Chim. Ada 514:15-26 (2004).
13. F.A. Maris, E. Dingler, and S.J. Niehues. High-performance liquid Chromatographie assay with fluorescence detection for the routine monitoring of the antidepressant mirtazapine and its demethyl metabolite in human plasma. Chromatogr. B Biomed. Sci. Appl. 721:309-316(1999).
14. P.E. Morgan, J. Tapper, and E.P. Spencer. Measurement of total mirtazapine and normirtazapine in plasma/serum by liquid chromatography with fluorescence detection, J. Chromatogr. B 798(2): 211-215(2003).
15. P. Ptacek, J. Klima, and J. Macek. Determination of mirtazapine in human plasma by liquid chromatography. J. Chromatogr. B 794 (2): 323-328 (2003).
16. S. Dodd, G.D. Burrows, and T.R. Norman. Chiral determination of mirtazapine in human blood plasma by high-performance liquid chromatography. J. Chromatogr. B 748:439-443 (2000).
17. Z.D. Zhai, Y.P Shi, and T. Wang. Development and validation of HPLC methods for enantioseparation of mirtazapine enantiomers at analytical and semipreparative scale using polysaccharide chiral stationary phases. Anal. Chim. Acta 550:123-129 (2005).
18. F.J. M. Santana, A.R.M. Oliveira, and P.S. Bonato. Chiral liquid Chromatographie determination of mirtazapine in human plasma using two-phase liquid-phase microextraction for sample preparation. Anal. Chim. Acta 549: 96-103 (2005).
19. N. Karasen and S. Altino. Determination of mirtazapine in tablets by UV spectrophotometric and derivative spectrophotometric methods. J. Pharm. Biomed. Anal. 24:11-17 (2000).
20. L. Labat, P. Dallet, E. Kummer, and J.P. Dubost. Spectrophotometric, spectrofluorimetric, HPLC and CZE determination of mirtazapine in pharmaceutical tablets. J. Pharm. Biomed. Anal. 28: 365-371 (2002).
21. G.S. Wynia, G. Windhorst, P.C. Post, and F.A. Maris. Development and validation of a capillary electrophoresis method within a pharmaceutical quality control environment and comparison with high-performance liquid chromatography. J. Chromatogr. A 773: 339-350(1997).